October 25,2010
Grassley Asks FDA about Medical Device Company Payments to Doctors in Clinical Studies
WASHINGTON – On Friday, Sen. Chuck Grassley of Iowa asked the Food and Drug Administration how the agency handles reports of medical device companies' payments to doctors who are participating in clinical studies of the companies' products.
Grassley wrote to the FDA commissioner, citing information that doctors participating in clinical trials sponsored by a particular medical device maker also received significant payments from that device maker.
“The FDA should be transparent and describe what it does with information about potential conflicts of interest, including any steps it takes to protect the integrity and reliability of clinical research,” Grassley said.
Next Article Previous Article
Recent News
- Wyden, Whitehouse Seek Justice Department Records on Trump Admin Interference That Reportedly Halted Caterpillar Investigation
- Wyden, Crapo Call for Swift Passage of Bipartisan PBM Reforms
- Wyden Statement at Finance Committee Hearing on President Biden’s Health Care Agenda
- Wyden Hearing Statement on the American Manufacturing Boom, the IRA and CHIPS and Science Act
- NEWS: Wyden, Sanders Press Federal Agencies to Protect Americans Against Surprise Medical Bills